Present Title & Affiliation
Director, Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology (IEO), Milan, Italy
Professor of Medical Oncology, University of Milan, Milan, Italy
Member, Advisory Board for Breast and Urogenital Cancer Programs, European Institute of Oncology (IEO), Milan, Italy
Professor of Medical Oncology, University of Milan, Milan, Italy
Member, Advisory Board for Breast and Urogenital Cancer Programs, European Institute of Oncology (IEO), Milan, Italy
Degree / Fellowship | Institution | Location | ||
---|---|---|---|---|
Education & Training | ||||
MD, cum laude | Catholic University of the Sacred Heart | Rome, Italy | ||
Specialization in Medical Oncology, cum laude | Catholic University of the Sacred Heart | Rome, Italy | ||
Research Fellowship, Clinical Immunology | Hollings Cancer Center, Medical University of South Carolina | Charleston, SC, USA | ||
Research Fellowship, Molecular Epidemiology | Herbert Irving Comprehensive Cancer Center, Columbia University | New York, NY, USA | ||
PhD, Medical Pathophysiology and Clinical Pharmacology | University of Pisa | Pisa, Italy | ||
Professional Positions & Employment | ||||
Director, Division of New Drugs and Early Drug Development for Innovative Therapies | European Institute of Oncology (IEO) | 2013 – Present | ||
Co-Director, Division of Medical Oncology | European Institute of Oncology (IEO) | 2010 – 2013 | ||
Director, Department of Medicine and Radiotherapy | European Institute of Oncology (IEO) | 2006 – 2010 | ||
Faculty, Unit of Clinical Pharmacology and New Drugs | European Institute of Oncology (IEO) | 1999 – 2006 | ||
Visiting Scientist | Dana-Farber Cancer Institute, Harvard Medical School | Boston, MA, USA (2011) | ||
Hospital Appointments | ||||
Hospital Appointments | ||||
Director, Division of New Drugs and Early Drug Development | European Institute of Oncology (IEO) | Milan, Italy | ||
Head, Department of Medical Hospitalization for Solid Tumors | IEO | Milan, Italy | ||
Institutional Leadership Activities | ||||
Director, Division of New Drugs Development | Leads all phase 0–II trials of innovative and targeted therapies across solid tumors. | |||
Member, Advisory Board on Breast and Urogenital Cancer | Provides strategic direction for multidisciplinary clinical and translational research programs. | |||
Member, Steering Committee | Oversees four global breast cancer studies (adjuvant, neoadjuvant, metastatic). | |||
Member, Independent Data Monitoring Committee | Adjuvant HER2-positive global trial program. | |||
Institutional Administrative Activities | ||||
Educational Chair, ESMO Task Force on Metastatic Breast Cancer | Coordinates international educational programs and scientific symposia. | |||
Member, Executive Committee | IEO Education – overseeing postgraduate and professional oncology training. | |||
Lecturer, Master in Oncologic Pharmacy | University of Milan – expert in targeted experimental therapies. | |||
Extramural Institutional Committee Activities | ||||
Scientific Advisory Council Member | International Breast Cancer Study Group (IBCSG) | |||
Scientific Advisory Council Member | Breast International Group (BIG) | |||
Board Member | European Society for Medical Oncology (ESMO) – Press & Media Affairs Committee | |||
Co-Founder and Scientific Secretary | International Cardio-Oncology Society (ICOS) | |||
Expert Clinical Assessor for Oncology | European Medicines Agency (EMA), appointed by AIFA | |||
Member, Faculty | St. Gallen Early Breast Cancer Conference; ESO; ESSO; ESTRO | |||
Chair | ESMO Task Force on Metastatic Breast Cancer (2014) | |||
Scientific Chair | IMPAKT Translational Research Conference on Breast Cancer (2014) | |||
Professional Organizations and Society Memberships | ||||
European Society for Medical Oncology (ESMO) | Faculty Member; Chair, Educational Task Forces | |||
American Society of Clinical Oncology (ASCO) | Member | |||
American Association for Cancer Research (AACR) | Member | |||
Italian Association of Medical Oncology (AIOM) | Member | |||
European School of Oncology (ESO) | Faculty Member | |||
International Cardio-Oncology Society (ICOS) | Co-Founder | |||
European Society of Surgical Oncology (ESSO) | Faculty Member | |||
European Society for Radiotherapy and Oncology (ESTRO) | Faculty Member | |||
Honors & Awards | ||||
Doctor cum laude | Catholic University of the Sacred Heart | |||
Doctorate in Medical Pathophysiology and Clinical Pharmacology | University of Pisa | |||
Scientific Leadership Award | European Society for Medical Oncology (ESMO) | |||
Educational Excellence Recognition | European School of Oncology (ESO) | |||
Honorary Faculty Appointment | Harvard Medical School (Visiting Scientist, 2011) |
Office address: European Institute of Oncology (IEO), Via Ripamonti 435, 20141 Milan, Italy
Office telephone: +39 02 5748 9599
Work email: [email protected]